
See related research article by Singh and colleagues on page [1359][1] and at [www.cmaj.ca/lookup/doi/10.1503/cmaj.110218][2] and related letters on page [1404][3]. In this issue of CMAJ , Singh and colleagues[1][4] present a meta-analysis assessing the risk of serious adverse cardiovascular events
Cardiovascular Diseases, Quinoxalines, Humans, Nicotinic Agonists, Benzazepines, Varenicline
Cardiovascular Diseases, Quinoxalines, Humans, Nicotinic Agonists, Benzazepines, Varenicline
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 11 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
